These targets may be the key points of the therapeutic action of quercetin in GC, although several experiments have proven that quercetin can inhibit the expression of AKT1 [76], EGFR [77], SRC [78], IGF1R [79], PTK2 [80], and KDR [81]. Here, IGF1R is linked to gastric cancer.